Trial Condition(s):
DUB/OC: QT prolongation
91516
Not Available
Not Available
Please see attached Study Results Summary below
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations | |
---|---|
Locations Bayer Pharma AG Berlin, Germany, 13353 | Contact Us: E-mail: [email protected] Phone: Not Available |